Source: FDA, National Drug Code (US) Revision Year: 2023
Each capsule for oral use, with opaque red cap and body, contains Triamterene USP, 50 or 100 mg, and is imprinted with the product name, DYRENIUM, strength (50 mg or 100 mg) and WPC 002 (for the 50-mg strength) and WPC 003 (for the 100-mg strength). Inactive ingredients consist of D&C Red No. 33, FD&C Yellow No. 6, Gelatin NF, Lactose NF, Magnesium Stearate NF, and Titanium Dioxide USP.
Triamterene is 2,4,7-triamino-6-phenyl-pteridine:
Its molecular weight is 253.27. At 50°C, triamterene is slightly soluble in water. It is soluble in dilute ammonia, dilute aqueous sodium hydroxide and dimethylformamide. It is sparingly soluble in methanol.
| How Supplied |
|---|
|
Capsules: 50 mg in bottles of 100, and 100 mg in bottles of 100. 50 mg 100s: NDC 59212-002-01 100 mg 100s: NDC 59212-003-01 Mfd. for: Concordia Pharmaceuticals Distributed by: Amdipharm Limited, 17 Northwood House, Dublin 9, Ireland |
| Drug | Countries | |
|---|---|---|
| DYRENIUM | United States |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
